About Nova Biomedical
Nova Biomedical is a company based in Waltham (United States) founded in 1976 was acquired by Advanced Instruments in March 2025. Nova Biomedical operates in a competitive market with competitors including SD Biosensor, 1Drop Diagnostics, DiabetOmics, BioHermes and DxGen, among others.
- Headquarter Waltham, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nova Biomedical Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Advanced Instruments
(Mar 19, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Nova Biomedical
Unlock access to complete
Unlock access to complete
Funding Insights of Nova Biomedical
Detailed funding history for Nova Biomedical
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Nova Biomedical
Nova Biomedical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Advanced Instruments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of Laboratory equipment
|
Locked | Locked | Locked |
Investor details for Nova Biomedical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nova Biomedical
Investment portfolio details for Nova Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nova Biomedical
Detailed financials for Nova Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nova Biomedical Comparisons
Peer comparison for Nova Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nova Biomedical
Nova Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SD Biosensor, 1Drop Diagnostics, DiabetOmics, BioHermes and DxGen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| Locked | Locked | Locked |
Finger-prick point-of-care diagnostics are provided for biomarker testing.
|
|
| Locked | Locked | Locked |
Point-of-care tests for diabetes and women's health risks are developed.
|
|
| Locked | Locked | Locked |
Provider of POC diagnostic devices and kits
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic products for diabetes and tuberculosis are provided.
|
|
| Locked | Locked | Locked |
Glycated albumin measurement devices are developed for diagnostics.
|
Detailed competitors of Nova Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nova Biomedical
Complete news archive for Nova Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nova Biomedical
Nova Biomedical was founded in 1976.
Nova Biomedical is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Developer of advanced blood testing analyzers and meters. This company manufactures and sells a wide variety of analyzers for hospital, point-of-care, blood bank, biotechnology, veterinary, and sports medicine applications. Products include blood gas analyzers, glucose meters, lactate meters, and cell culture analyzers. They also offer contract development and manufacturing services for other medical device companies. The analyzers utilize various measurement technologies, including potentiometric, amperometric, and spectrophotometric methods. The company provides complete technical support and product information globally.
Nova Biomedical's top competitors include SD Biosensor, 1Drop Diagnostics and Labrador Sciences.
Nova Biomedical has 1 investor. Key investors include Advanced Instruments.